How Matrix Metalloproteinases Regulate Cell Behavior

Annual Review of Cell and Developmental Biology - Tập 17 Số 1 - Trang 463-516 - 2001
Mark D. Sternlicht1, Zena Werb1
1Department of Anatomy, University of California, San Francisco, California 94143-0452

Tóm tắt

▪ Abstract  The matrix metalloproteinases (MMPs) constitute a multigene family of over 25 secreted and cell surface enzymes that process or degrade numerous pericellular substrates. Their targets include other proteinases, proteinase inhibitors, clotting factors, chemotactic molecules, latent growth factors, growth factor–binding proteins, cell surface receptors, cell-cell adhesion molecules, and virtually all structural extracellular matrix proteins. Thus MMPs are able to regulate many biologic processes and are closely regulated themselves. We review recent advances that help to explain how MMPs work, how they are controlled, and how they influence biologic behavior. These advances shed light on how the structure and function of the MMPs are related and on how their transcription, secretion, activation, inhibition, localization, and clearance are controlled. MMPs participate in numerous normal and abnormal processes, and there are new insights into the key substrates and mechanisms responsible for regulating some of these processes in vivo. Our knowledge in the field of MMP biology is rapidly expanding, yet we still do not fully understand how these enzymes regulate most processes of development, homeostasis, and disease.

Từ khóa


Tài liệu tham khảo

10.1074/jbc.274.33.23443

10.1083/jcb.135.6.1669

10.1083/jcb.152.4.693

10.1016/S0002-9440(10)64541-5

10.1042/0264-6021:3400171

10.1074/jbc.M009586200

Banda MJ, 1988, J. Biol. Chem., 263, 4481, 10.1016/S0021-9258(18)68951-3

Barcellos-Hoff MH, 2000, Cancer Res., 60, 1254

10.1074/jbc.274.42.30087

10.1016/0006-291X(75)90243-0

10.1074/jbc.M003834200

10.1074/jbc.M010135200

10.1038/35036374

10.1378/chest.116.suppl_1.17S-a

10.1165/ajrcmb.20.6.3558

10.1128/MCB.17.11.6330

Bodden MK, 1994, J. Biol. Chem., 269, 18943, 10.1016/S0021-9258(17)32258-5

10.1074/jbc.M007929200

10.1002/(SICI)1097-4652(199807)176:1<206::AID-JCP22>3.0.CO;2-3

10.1016/S0092-8674(00)80931-9

10.1016/S0092-8674(00)81235-0

10.1146/annurev.cellbio.14.1.111

10.1111/j.1749-6632.1999.tb07775.x

10.1097/00000658-199908000-00017

10.1074/jbc.273.52.34745

10.1074/jbc.M001920200

10.1182/blood.V86.12.4506.bloodjournal86124506

10.1073/pnas.94.6.2374

10.1016/S0092-8674(00)00139-2

10.1038/sj.onc.1202627

10.1172/JCI2182

10.1016/0092-8674(92)90391-O

10.1128/MCB.15.10.5732

10.1074/jbc.270.44.26607

10.1074/jbc.M004538200

10.1006/excr.2000.5118

10.1165/ajrcmb.22.2.3809

10.1002/1098-2744(200009)29:1<8::AID-MC2>3.0.CO;2-0

10.1172/JCI8768

10.1172/JCI1516

10.1046/j.1523-1755.2000.00208.x

Edwards DR. 2001.The tissue inhibitors of metalloproteinases (TIMPs).InMatrix Metalloproteinase Inhibitors in Cancer Therapy, ed. NJ Clendeninn, K Appelt. pp. 67–84. Totowa, NJ: Humana

10.1172/JCI6869

10.1074/jbc.275.19.14046

10.1083/jcb.151.4.879

10.1073/pnas.97.8.3884

Filvaroff E, 1999, Development, 126, 4267, 10.1242/dev.126.19.4267

Fingleton B, 1999, Clin. Exp. Metastasis, 17, 769

10.1016/B978-012545090-4/50013-6

10.1111/j.1749-6632.1999.tb07765.x

10.1038/9467

10.1126/science.277.5323.225

Gomez DE, 1997, Eur. J. Cell Biol., 74, 111

10.1038/37995

10.1073/pnas.48.6.1014

10.1172/JCI2881

Guo H, 2000, Cancer Res., 60, 888

10.1006/geno.1998.5401

10.1002/j.1460-2075.1990.tb07394.x

Ha HY, 2001, Cancer Res., 61, 984

10.1016/S0092-8674(00)80108-7

10.1172/JCI7090

10.1172/JCI7091

10.1021/bi00792a008

Hasty KA, 1990, J. Biol. Chem., 265, 11421, 10.1016/S0021-9258(19)38413-3

10.1126/science.277.5334.2002

10.1002/(SICI)1097-0215(19981123)78:5<629::AID-IJC17>3.3.CO;2-#

10.1038/13459

10.1074/jbc.M001836200

10.1016/S0092-8674(00)81768-7

10.1074/jbc.M008157200

10.1016/S0092-8674(00)80064-1

10.1083/jcb.149.6.1309

Howard EW, 1991, J. Biol. Chem., 266, 17972, 10.1016/S0021-9258(18)55224-8

10.1074/jbc.272.35.22086

10.1042/bj3220809

Imai K, 1996, Cancer Res., 56, 2707

10.1172/JCI119803

10.1111/j.1749-6632.1999.tb09400.x

10.1074/jbc.271.25.14657

Itoh T, 1998, Cancer Res., 58, 1048

10.1074/jbc.273.38.24360

10.1074/jbc.274.48.34260

10.1038/81563

10.1128/MCB.19.6.4431

10.1161/01.RES.86.9.998

Kanamori Y, 1999, Cancer Res., 59, 4225

10.1074/jbc.C000848200

10.1016/S0002-9440(10)65292-3

10.1126/science.280.5365.898

10.1093/jnci/86.4.299

10.1126/science.2465572

10.1016/S0092-8674(00)81478-6

10.1073/pnas.89.10.4693

10.1126/science.280.5366.1036

10.1016/S0014-5793(97)00158-0

10.1016/S0014-5793(00)01919-0

Koop S, 1994, Cancer Res., 54, 4791

Kraling BM, 1999, J. Cell Sci., 112, 1599, 10.1242/jcs.112.10.1599

10.1182/blood.V90.5.1993

10.1016/S0002-9440(10)64815-8

10.1074/jbc.273.27.16778

Langton KP, 2000, J. Biol. Chem., 275, 27027, 10.1016/S0021-9258(19)61475-4

10.1084/jem.193.7.793

Leontovich AA, 2000, Development, 127, 907, 10.1242/dev.127.4.907

10.1002/j.1460-2075.1990.tb07493.x

10.1073/pnas.93.14.7069

10.1016/S0945-053X(00)00121-9

10.1161/01.ATV.19.12.2863

10.1083/jcb.130.1.227

10.1016/S0092-8674(00)00087-8

10.1074/jbc.M006045200

10.1083/jcb.139.7.1861

10.1016/S0945-053X(96)90149-3

10.1016/S0378-1119(99)00549-1

10.1074/jbc.M001599200

10.1074/jbc.M007529200

10.1016/S0962-8924(98)01362-2

10.1093/emboj/18.17.4645

10.1074/jbc.C000186200

10.1074/jbc.274.49.34706

10.1074/jbc.272.41.25706

10.1006/excr.2000.5063

10.1038/90100

10.1083/jcb.146.4.881

Martin DC, 1996, Oncogene, 13, 569

10.1083/jcb.140.6.1535

10.1016/S0960-9822(00)80011-1

10.1104/pp.99.3.1179

10.1007/BF03401787

10.1126/science.289.5482.1202

Mitsiades N, 2001, Cancer Res., 61, 577

10.1006/bbrc.1999.2050

10.1074/jbc.273.40.25903

Moinfar F, 2000, Cancer Res., 60, 2562

10.1074/jbc.275.2.1384

10.1002/1529-0131(199801)41:1<110::AID-ART14>3.3.CO;2-7

10.1074/jbc.274.9.5588

Murphy G, 1992, J. Biol. Chem., 267, 9612, 10.1016/S0021-9258(19)50134-X

Murphy G, 1994, J. Biol. Chem., 269, 6632, 10.1016/S0021-9258(17)37419-7

10.1016/0076-6879(95)48032-3

10.1074/jbc.274.31.21491

10.1073/pnas.94.15.7959

10.1200/JCO.2000.18.5.1135

10.1002/pro.5560070610

Noe V, 2001, J. Cell Sci., 114, 111, 10.1242/jcs.114.1.111

10.1074/jbc.270.39.22866

10.1016/S0002-9440(10)64011-4

10.1074/jbc.274.41.29568

10.1021/bi00157a002

10.1016/S0014-5793(96)01523-2

10.1074/jbc.273.17.10672

10.1111/j.1749-6632.1999.tb07706.x

Overall CM. 2001.Matrix metalloproteinase substrate binding domains, modules and exosites.InMatrix Metalloproteinase Protocols, ed. IM Clark, pp. 79–120. Totowa, NJ: Humana

Overall CM, 1991, J. Biol. Chem., 266, 14064, 10.1016/S0021-9258(18)92810-3

10.1074/jbc.M002349200

10.1074/jbc.272.46.28823

10.1038/375244a0

10.1006/geno.1996.4554

10.1126/science.282.5392.1281

10.1074/jbc.275.11.8051

Petitclerc E, 1999, Cancer Res., 59, 2724

10.1073/pnas.220399597

10.1111/j.1749-6632.1999.tb07671.x

10.1016/S0960-9822(00)80113-X

10.1073/pnas.040378497

10.1074/jbc.271.20.11634

10.1074/jbc.M010242200

10.1016/S0168-9525(99)01926-5

10.1172/JCI8931

10.1006/excr.1997.3681

10.1074/jbc.M005788200

10.1091/mbc.9.2.421

Rudolph-Owen LA, 1998, Cancer Res., 58, 5500

10.1002/jlb.66.3.416

Rutter JL, 1998, Cancer Res., 58, 5321

Sanchez-Lopez R, 1993, J. Biol. Chem., 268, 7238, 10.1016/S0021-9258(18)53168-9

Sheu BC, 2001, Cancer Res., 61, 237

10.1074/jbc.271.8.4335

10.1093/carcin/18.11.2093

10.1016/S1097-2765(00)80004-0

10.1073/pnas.011343298

Soloway PD, 1996, Oncogene, 13, 2307

Sottrup-Jensen L, 1989, J. Biol. Chem., 264, 393, 10.1016/S0021-9258(17)31271-1

10.1517/14728222.4.5.609

10.1038/sj.onc.1203347

Sternlicht MD, Coussens LM, Vu TH, Werb Z. 2001.Biology and regulation of the matrix metalloproteinases.InMatrix Metalloproteinase Inhibitors in Cancer Therapy, ed. NJ Clendeninn, K Appelt, pp. 1–37. Totowa, NJ: Humana

10.1016/S0092-8674(00)81009-0

Sternlicht MD, Werb Z. 1999.ECM proteinases.InGuidebook to the Extracellular Matrix,Anchor and Adhesion Proteins, ed. T Kreis, R Vale, pp. 503–62. Oxford, UK: Oxford Univ. Press

10.1002/pro.5560040502

10.1074/jbc.275.20.14809

10.1016/S0955-0674(99)00026-5

Stricker TP, 2000, Mol. Biol. Cell, 11, 258a

10.1074/jbc.270.10.5331

10.1074/jbc.274.17.11535

10.1074/jbc.272.50.31730

10.1083/jcb.125.3.681

10.1016/S0014-5793(99)00119-2

10.1126/science.284.5420.1664

10.1002/(SICI)1097-4652(199907)180:1<131::AID-JCP15>3.0.CO;2-S

10.1074/jbc.273.16.9769

Uria JA, 2000, Cancer Res., 60, 4745

10.1073/pnas.87.14.5578

Vincenti MP. 2001.The matrix metalloproteinase (MMP) and tissue inhibitor of metalloproteinase (TIMP) genes.InMatrix Metalloproteinase Protocols, ed. IM Clark, pp. 121–48. Totowa, NJ: Humana

10.1016/S1097-2765(00)80003-9

10.1016/S0092-8674(00)81169-1

10.1016/S0378-1119(98)00076-6

10.1073/pnas.96.12.6885

10.1523/JNEUROSCI.20-18-07037.2000

10.1074/jbc.M001270200

10.1016/S0092-8674(00)80429-8

10.1126/science.282.5392.1279

10.1164/ajrccm/150.6_Pt_2.S165

10.1016/S0002-9440(10)65438-7

10.1021/bi9712091

10.1073/pnas.94.4.1402

10.1126/science.286.5437.113

Windsor LJ, 1993, J. Biol. Chem., 268, 17341, 10.1016/S0021-9258(19)85340-1

10.1074/jbc.274.30.21362

Woessner JF, 2000, Matrix Metalloproteinases and TIMPs., 10.1093/oso/9780198502685.001.0001

10.1101/gad.12.9.1315

10.1091/mbc.11.10.3353

10.1074/jbc.M008925200

10.1016/S0945-053X(00)00102-5

10.1002/(SICI)1097-0215(19980105)75:1<81::AID-IJC13>3.3.CO;2-J

Yu Q, 2000, Genes Dev., 14, 163, 10.1101/gad.14.2.163

10.1074/jbc.275.6.4183

10.1161/01.CIR.99.14.1788

10.1073/pnas.060037197

10.1074/jbc.273.2.1216

Thông tin
Thông tin xuất bản

Annual Review of Cell and Developmental Biology

Tập 17 Số 1

463-516

Thông tin tác giả